Reporter Staff

Reporter Staff

| This email address is being protected from spambots. You need JavaScript enabled to view it.

The UAB Sexual Health Research Clinic is recruiting women ages 18 to 45 to assess the safety, tolerability, and efficacy of a new vaginal suppository in women diagnosed with bacterial vaginosis (BV). Eligible participants will be compensated for each completed visit.

  • Are 18–45 years of age?
  • Are you pre-menopausal?
  • Have you been on birth control for the last 3 months and plan to continue use?
  • Are you currently having any vaginal symptoms?
  • Are you willing to abstain from sexual intercourse for at least one month?

Interested? Contact 205-934-8166 for more information.

Do you want to make a difference for kids? More children are at risk for type 2 diabetes, and you can help us learn why.

Type 2 diabetes is diagnosed when the body has problems with high blood sugar levels. This can lead to serious health problems if not identified and treated early.

DISCOVERY is a study for children 9-14 years old who may be at higher risk of developing type 2 diabetes.

What will happen in the study?

  • In person and phone visits
  • Lab tests
  • Questionnaires
  • Physical exams
  • Glucose (blood sugar) monitors

Join families across the US to help us make a difference for all children and young people! This study does not involve medications and there is no cost to you. You will be compensated for your time in this study.

Contact us for more information:
205-517-1351
Discovery@uab.edu

After an extensive national search, UAB has named Kevyn E. Merten, Ph.D., as the senior associate vice president for Research Operations, effective Jan. 14. Merten will be responsible for the day-to-day operations of the Office of Research. He joins UAB from the University of Louisville.
Learn more about the seven 2024 awardees, which received pledges for more than $12 million over three years. The SIF backs cross-campus projects — designed and led by UAB faculty and staff — that align with the university’s strategic plan, Forging Ahead.

The AWARE Disability Management Program is celebrating Veterans Day all month long with events and programs to honor the armed forces and give back to those who served.

This month, UAB Employee Wellness is spotlighting the impact pets have on our mental health — including those experiencing seasonal mood shifts — by bringing back its UAB’s Cutest Pet Contest. UAB employees are invited to submit pictures of pets now through Nov. 14.
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
We are looking for volunteers to participate in a clinical study to advance lupus treatment.

If you are interested in seeing if you may qualify for an ongoing clinical study, please contact Christina Ndolo at cmndolo@uabmc.edu.
Participate in the PRECISION-BP research study investigating the best time to take blood pressure medication, morning or evening. This study participants will receive blood pressure medications for 28 days. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.
The Denosumab for Type 1 Diabetes phase 1/2 clinical trial, is a collaborative study with the Arthur Riggs Diabetes and Metabolism Research Institute and the Center for Diabetes and Metabolic Diseases at Indiana University.
Page 2 of 71